By creating an account on our website you will be able to shop faster, be up to date on an orders status, and keep track of the orders you have previously made.
Vibose 0.2 is a medicine used to treat type 2 diabetes mellitus. It helps control the high blood sugar levels in your body after each meal. It is used when other similar medicines along with a restricted diet, are unable to control abnormally high blood sugar levels. Vibose 0.2 should be taken just before a meal or along with the first mouthful of food. The dose and how often you need it will be decided by your doctor so that you get the right amount to control your blood sugar levels. The dose may be increased gradually. Do not stop...
...
Uses of Vibose 0.2
Type 2 diabetes mellitus
Side effects of Vibose 0.2
Common
Skin rash
Flatulence
Abdominal pain
Diarrhea
How to use Vibose 0.2
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Vibose 0.2 is to be taken with food.
How Vibose 0.2 works
Vibose 0.2 is an anti-diabetic medicine. It inhibits the intestinal enzymes responsible for breaking complex sugars into simple sugars such as glucose. This prevents blood glucose levels from rising very high immediately after meals.
What if you forget to take Vibose 0.2?
If you miss a dose of Vibose 0.2, skip it and continue with your normal schedule. Do not double the dose.
Quick Tips
Vibose 0.2 is used together with other diabetes medicines to control blood sugar and avoid long-term complications.
You should continue to exercise regularly, eat a healthy diet, and take your other diabetes medicines along with Vibose 0.2.
Vibose 0.2 lowers your post-meal blood sugar levels. Therefore, it should be taken before meals.
Side effects such as stomach pain, gas, and diarrhea may occur during the first few weeks of treatment but should get better with time.
Brief Description
Indication
Diabetes mellitus
Administration
Should be taken with food. Take just before meals.
Adult Dose
Oral
Diabetes mellitus
Adult: 200-300 mcg tid.
Elderly: Initiate at lower doses.
...
Contraindication
Inflammatory bowel disease; GI obstruction or patients predisposed to it; conditions which may deteriorate as a result of increased gas formation eg, hernia; severe ketosis; diabetic coma or pre-coma; severe infection; hypersensitivity; pregnancy; lactation. Not to be used as monotherapy in IDDM.
Mode of Action
Voligbose has general properties similar to acarbose and selectively inhibits α-glucosidase in the enteric canal, delaying the digestion and absorption of carbohydrate, thereby suppressing sharp increase in post-prandial plasma glucose.
Precaution
History of laparotomy or ileus. Roemheld's syndrome, stenosis, severe hepatic or renal impairment. Child <18 yr; elderly. Monitor LFT. Treat hypoglycaemic episodes with glucose (not with sucrose).